CN
99-83-2
应用筛选条件
关键词:'99-83-2'
显示 1-30 共 248 条结果 关于 "99-83-2" 范围 技术文档
The Effective Use of Protein Kinase Inhibitors
100 99 108 92 89 116
SAPK4/p38δ 105 95 103 130 110 111 98 94 93 87 79 94 103 82 84 99 104 113 133
MAPKAP-K1a
MAPKAP-K1b 16 72 37 79 89 88 86 93 83
The Effective Use of Protein Kinase Inhibitors
100 99 108 92 89 116
SAPK4/p38δ 105 95 103 130 110 111 98 94 93 87 79 94 103 82 84 99 104 113 133
MAPKAP-K1a
MAPKAP-K1b 16 72 37 79 89 88 86 93 83
Product Information Sheet - A5666
Blood, 99(3),
850-855 (2002).
4. Baerlocher, G. M., et al., Telomere length
measurement by fluorescence in situ hybridization
and flow cytometry: tips and pitfalls. Cytometry,
47(2), 89-99 (2002
Product Information Sheet - A0171
Blood, 99(3),
850-855 (2002).
4. Baerlocher, G. M., et al., Telomere length
measurement by fluorescence in situ hybridization
and flow cytometry: tips and pitfalls. Cytometry,
47(2), 89-99 (2002
Poster: Purification with Millipore MultiScreen 384SEQ Plates on Beckman-Coulter’s Biomek FX for High Quality Direct Sequencing in High-Throughput Genomics
.12 93% no resequencing necessary
Averages: 37 323 87% Averages: 37 321 83% Averages: 39 353 94%
Set 1 Set 2 Set 3
1/2 rxn
ethanol
1/4 rxn
ethanol
1/4 rxn
MultiScreen384SEQ
Average
MMP Activation Chart
/21712
activeMMP-7 1:1 37oC, 4h 83 & 80 78 74.6* L
16RTNL; C-term
cleavage
0.25x Imai, jbc270/1995/6691
APMA, 1mM +
activeMMP-7 (1:1)
37oC, 12h 83 62 66.6* M
75RTPR & F88QTFE; C-
Quality Control Range Sheet- MCKP1-102 and MCKP1-202
ml
Control 2 632 - 1312 pg/mL Control 2 111 - 232 pg/ml
TIM-3 Control 1 46 - 95 pg/mL CD25/IL-2Rα Control1 21
Barbital solution (B8632)
2008
Storage 2-8°C; After opening, transfer contents to
small vial provided for your convenience.
70 eV Electron Ionization Mass Spectrum
Abundance
41
83
98
Data Sheet - E1132 - Lot 049H8801
175 - 176°
Specific rotation, [α]D
25
10 mg/mL solution in dioxane 〈781〉
between +76° and +83° + 77°
Water Method 1 〈921〉 not more than 3.5% 3.3%
Chromatographic purity 〈621〉 not more than
Product Information Sheet - 330752
dry place.
REFERENCES
1 Eckert, Hl; Forster, B. Angew. Chem. 1987, 99, 922 (Angew.
Chem., Int. Ed. Engl. 1987, 26, 894).
2 Eckert, H. Ger. Offen. DE 3 440 141, 1986; Chem. Abstr.
1987, 106, 4294d
Bulletin - 857365P
)-Phosphoric acid mono-[2-amino-3-(4-octyl-phenylamino)-propyl] ester (VPC 24191)
Catalog Number 857365 Physical state Powder
Purity > 99% Transition temp. No data
CAS 799268-83-0 CMC No data
Synonyms
Data Sheet - L4787
, L. A., et al., Cell 83: 1263-1271, 1995.
2. Cioffi, J. A., et al., Nat. Med. 2: 585-589, 1996.
3. Wang, Y., et al., J. Biol. Chem. 272: 16216-16223,
1997.
EMM 10/7/99
Product Information Sheet - P3755
407(1), 83-94
(2002).
5. Theodossiou, C., and Schwarzenberger, P.,
Propylthiouracil reduces xenograft tumor growth in
an athymic nude mouse prostate cancer model.
Am. J. Med. Sci., 319(2), 96-99
Anti-Cannabinoid Receptor 1 (C1108)
Rev. Pharmacol.
Toxicol., 38, 179-200 (1998).
2. Twitchell, W., et al., J. Neurophysiol., 78, 43-50
(1997).
3. Tsou, K., et al., Neuroscience, 83, 393-411 (1998).
4. Pertwee, R.G., Curr. Med. Chem
Data Sheet - A4839
repeated freeze-thaw cycles.
References
1. De Winter J., et al., Mol. Cell Endocrinol, 83:105
(1992).
2. Smith, J., et al., Cell, 67:79 (1991).
3. De Winter, J., et al., Endocrinology, 132:975
Product Information Sheet - P4633
implications concerning
the study of estrogen-responsive cells in culture.
Proc. Natl. Acad. Sci. USA, 83(8), 2496-2500
(1986).
5. Bindal, R. D., et al., Lipophilic impurities, not
phenolsulfonphthalein
Product Information - P4758
implications concerning
the study of estrogen-responsive cells in culture.
Proc. Natl. Acad. Sci. USA, 83(8), 2496-2500
(1986).
5. Bindal, R. D., et al., Lipophilic impurities, not
phenolsulfonphthalein
Product Information - P5530
implications concerning
the study of estrogen-responsive cells in culture.
Proc. Natl. Acad. Sci. USA, 83(8), 2496-2500
(1986).
5. Bindal, R. D., et al., Lipophilic impurities, not
phenolsulfonphthalein
Data Sheet - E8905
References
1. Nagao, M., et al., Biochim. Biophys. Acta., 117,
99-102 (1992).
2. Lacombe, C., and Maeux, O., Haematologica,
83, 724-732 (1998).
3. Egrie, J., et al., Human Cytokines, Aggarwal
Data Sheet - T9533
., et al., J.Biol. Chem., 257, 14628 (1982).
10. Ibbotson, K., et al., Proc. Natl. Acad. Sci. USA, 83,
2228 (1986).
11. Schreiber, A., et al., Science, 232, 1250 (1986).
12. Kobrin, M., et al., J
Product Information Sheet - M7391
or medicine? N. Z. Med. J., 99(800), 281-283
(1986).
6. Gomara, M. J., et al., Effects of sphingomyelin on
melittin pore formation. Biochim. Biophys. Acta,
1612(1), 83-89 (2003).
7. Koumanov, K
RABBIT ANTI-EPITHELIAL SODIUM CHANNEL ALPHA (ENaC alpha) AFFINITY PURIFIED POLYCLONAL ANTIBODY
1) Linguela E et al (1993) FEBS Lett. 318:95-99; Canessa CM et al (1993) Nature
361:467-470; Snyder PM et al (1994) J. Biol. Chem. 269:24379-83; Waldmann R et al
(1995) J. Biol. Chem. 270:11735-
Product Information Sheet - M2272
or medicine? N. Z. Med. J., 99(800), 281-283
(1986).
6. Gomara, M. J., et al., Effects of sphingomyelin on
melittin pore formation. Biochim. Biophys. Acta,
1612(1), 83-89 (2003).
7. Koumanov, K
QC Range Sheet MCKP1-110K
ml
Control 2 614 - 1276 pg/mL Control 2 105 - 217 pg/ml
TIM-3 Control 1 43 - 88 pg/mL CD25/IL-2Rα Control1 19
Data Sheet - P7956
ATP
to histone H1 at pH 7.4 at 30 °C.
References
1. Kikkawa, U., et al., Meth. Enzymol., 99, 288 (1983).
2. Dong, L.Q., et al., Primary structure, tissue
distribution, and expression of mouse
phosphoinositide-dependent
Data Sheet - SAB4200484
optimal working dilutions by titration.
References
1. Zhang, F., et al., Cardiovas. Res., 83, 7–15 (2009).
2. Serru, V., et al., Biochim. Biophys. Acta, 1478, 159-
163 (2000).
3. Bennett, G., et al
Natural Lineage Markers
cytoskeleton ENSG00000130402 IHC,WB 99 / 98%
HPA006035 Anti-ACTN1 cytoskeleton ENSG00000072110 IHC,WB 98 / 99%
HPA008057 Anti-INA cytoskeleton ENSG00000148798 IHC 83 / 84%
HPA023138 Anti-NEFM cytoskeleton
Quality Control Ranges: Human Cytokine/ Chemokine/Growth Factor Magnetic Bead Panel A
pg/ml
Control 2 133 - 558 pg/mL Control 2 1233 - 2561 pg/ml
IL-1β Control 1 50 - 103 pg/mL IL-17A Control1 40
Quality Control Range Sheet- A6602-106 and A6602-206
210 pg/mL IL-2 Control 1 17 – 36 pg/mL
Control 2 450 – 935 pg/mL Control 2 85 – 177 pg/mL
FGF-2 Control 1 624
1/9